Our Helplines
1-877-327-4636 Alcohol and Substance
1-800-436-8477 Morning Sickness
1-888-246-5840 HIV and HIV Treatment
1-877-439-2744 Motherisk Helpline
416-813-6780 Motherisk Helpline
Pregnancy & Breastfeeding Resources
Current Studies at Motherisk
-
Study seeks women between 4 and 12 weeks in their pregnancy with morning sickness (NVP)
-
Pregnancy in Women with Multiple Sclerosis
-
Environmental Exposures and Children's Health
-
Alcohol Use during Pregnancy
-
Control of Hypertension in Pregnancy Study
-
Folic Acid Before and During Pregnancy
-
Lamisil in Pregnancy
-
Meridia in Pregnancy
-
Autoimmune Diseases in Pregnancy Project
Motherisk News: Establishing a new Benchmark for Drug Evaluation During Pregnancy
View the 'Establishing a new Benchmark for Drug Evaluation During Pregnancy' Registration Form [ pdf ].
| May 10, 2006 - Hilton Hotel - 145 Richmond St. W, Toronto (Toronto I Room) | |
| 7:30 to 8:30: | Registration & Breakfast |
| 8:30 to 8:45: | Welcome and Opening Remarks Dr. Gideon Koren - Founding Director, Motherisk Program, Hospital for Sick Children, Toronto |
| 8:45 to 9:05: |
NIH New Strategy for Drug Research in Pregnancy Dr. Donald Mattison - Senior Advisor to the National Institute of Child Health and Human Development; Center for Research for Mothers and Children |
| 9:05 to 9:15: | Question period |
| 9:15 to 9:45: |
Issues in Using Drugs in Pregnancy: The Balance of Safety, risk and the Unknown Dr. Gideon Koren - Founding Director, Motherisk Program, Hospital for Sick Children, Toronto |
| 9:45 to 10:00: | Question period |
| 10:00 to 10:15: | Break |
| 10:15 to 10:35: | Drugs used in Pregnancy: The Regulatory Process Anne Tomalin - President, CanReg Inc. |
| 10:35 to 10:45: | Question period |
| 10:45 to 11:05: |
Challenges in Drug Use Near Term and During Delivery Dr. Dan Farine - Perinatologist, Mount Sinai Hospital, Toronto |
| 11:05 to 11:15: | Question period |
| 11:15 to 11:30: |
Collection and Analysis of Safety Drug Data in Pregnancy Myla Moretti - Assistant Director, Motherisk Program, Hospital for Sick Children, Toronto |
| 11:30 to 11:40: | Question period |
| 11:40 to 11:50: |
Forty Five Years Later ... Where Do We Stand! Mercedes Benegbi - Executive Director, Thalidomide Victims Association of Canada |
| 11:50 to 12:00: | Closing remarks Dr. Gideon Koren |












![Validate my RSS feed [Valid RSS]](/images/rssValid.png)